Skip to main content

Advertisement

SpringerLink
Log in

Neues zu HIV-Therapiestrategien, Nebenwirkungen und Resistenzentwicklung Bericht von der European Conference on Clinical Aspects and Treatment of HIV-Infection (ECCAT) in Lissabon und der 39th Interscience conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco

Bericht von der European Conference on Clinical Aspects and Treatment of HIV-Infection (ECCAT) in Lissabon und der 39th Interscience conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco

  • Tagungsberichte
  • Published:
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Rights and permissions

Reprints and permissions

About this article

Cite this article

, . Neues zu HIV-Therapiestrategien, Nebenwirkungen und Resistenzentwicklung Bericht von der European Conference on Clinical Aspects and Treatment of HIV-Infection (ECCAT) in Lissabon und der 39th Interscience conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco. Bundesgesundheitsbl - Gesundheitsforsch - Gesundheitsschutz 43, 52–63 (2000). https://doi.org/10.1007/s001030050011

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s001030050011

Search

Navigation